biotechnology | Science and Enterprise

A group of Canadian academic labs and hospitals will begin a clinical trial testing antibodies from recovered Covid… https://t.co/BsfaYEhTGM
about 4 hours ago
New post on Science and Enterprise: Trial to Test Convalescent Antibodies for Covid-19 https://t.co/tWxVos72rq #Science #Business
about 4 hours ago
A company developing cancer immunotherapies is adapting its electronic-assisted process to create a vaccine protect… https://t.co/4Xg2tQlV57
about 1 day ago
New post on Science and Enterprise: Trial to Test Electronic-Aided Covid-19 Vaccine https://t.co/RPHi8QpchO #Science #Business
about 1 day ago
An industry group says rules for loans to small companies hard-hit by Covid-19 are changed to allow these loans for… https://t.co/k8OZb84rcC
about 1 day ago

Trial to Test Electronic-Aided Covid-19 Vaccine

By Alan, on April 6th, 2020%

A company developing cancer immunotherapies is adapting its electronic-assisted process to create a vaccine protecting against Covid-19 infections. . . . → Read More: Trial to Test Electronic-Aided Covid-19 Vaccine

Employers, Patients See Discounts from Biosimilars

By Alan, on April 3rd, 2020%

An analysis of health care spending by large employers shows both companies and their employees are saving money from using non-branded biologic therapies. . . . → Read More: Employers, Patients See Discounts from Biosimilars

Life Science Venture Funds Raise $2.56B for Start-Ups

By Alan, on April 2nd, 2020%

Two investment companies specializing in health care and life sciences revealed new venture funds to finance young enterprises with innovative technologies. . . . → Read More: Life Science Venture Funds Raise $2.56B for Start-Ups

Trial Shows Rare Disease Drug Treats Covid-19 Patients

By Alan, on April 1st, 2020%

Results from a clinical trial show a drug approved for a rare lymph node disease can stabilize or improve the condition of many people with severe Covid-19 complications. . . . → Read More: Trial Shows Rare Disease Drug Treats Covid-19 Patients

Start-Up Licenses Immunotherapies in $880M Deal

By Alan, on March 31st, 2020%

A new biotechnology enterprise creating treatments that alter chemical functions in immune cells agreed to license its technology to a pharmaceutical company. . . . → Read More: Start-Up Licenses Immunotherapies in $880M Deal

Biotechs Explore Cell Therapy for Covid-19 Antibodies

By Alan, on March 30th, 2020%

Two biotechnology companies are researching use of a non-viral gene therapy to deliver synthetic antibodies for treating Covid-19 infections. . . . → Read More: Biotechs Explore Cell Therapy for Covid-19 Antibodies

Sanofi, Biotech Partner on RNA Covid-19 Vaccine

By Alan, on March 27th, 2020%

Drug maker Sanofi and biotechnology company Translate Bio are creating a new vaccine to protect against the virus causing Covid-19 infections . . . → Read More: Sanofi, Biotech Partner on RNA Covid-19 Vaccine

Venture Fund to Back Covid-19 Start-Ups

By Alan, on March 24th, 2020%

A life science incubator company plans to fund eight start-up enterprises developing diagnostics, vaccines, or treatments for the Covid-19 pandemic. . . . → Read More: Venture Fund to Back Covid-19 Start-Ups

Trial to Test Arthritis Drug for Covid-19 Pneumonia

By Alan, on March 24th, 2020%

A clinical trial is beginning soon that tests a current drug for rheumatoid arthritis as a treatment for severe pneumonia in patients with Covid-19 infections. . . . → Read More: Trial to Test Arthritis Drug for Covid-19 Pneumonia

Engineered Blood Cells Created for Cancer Therapies

By Alan, on March 23rd, 2020%

An academic lab and spin-off company are developing engineered white blood cells with added cancer-killing proteins to attack solid tumor cancers. . . . → Read More: Engineered Blood Cells Created for Cancer Therapies

Science & Enterprise subscription

Specials

Follow us on Twitter

Guest Posts

Please share Science & Enterprise